Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 217 to 222 of 222 entries
Sorted by: Best Match Show Resources per page
[Treating lung cancer in primary care].

MMW Fortschritte der Medizin

Gillissen A, Kubicka S.
PMID: 33591524
MMW Fortschr Med. 2021 Feb;163(3):58-65. doi: 10.1007/s15006-021-9557-8.

No abstract available.

Cite
Gillissen A, Kubicka S. Lungentumoren - neue Therapien, bessere Prognose. [Treating lung cancer in primary care]. MMW Fortschr Med. 2021;163(3):58-65doi: 10.1007/s15006-021-9557-8.
Gillissen, A., & Kubicka, S. (2021). Lungentumoren - neue Therapien, bessere Prognose. [Treating lung cancer in primary care]. MMW Fortschritte der Medizin, 163(3), 58-65. https://doi.org/10.1007/s15006-021-9557-8
Gillissen, Adrian, and Kubicka, Stefan. "Lungentumoren - neue Therapien, bessere Prognose." [Treating lung cancer in primary care]. MMW Fortschritte der Medizin vol. 163,3 (2021): 58-65. doi: https://doi.org/10.1007/s15006-021-9557-8
Gillissen A, Kubicka S. Lungentumoren - neue Therapien, bessere Prognose. [Treating lung cancer in primary care]. MMW Fortschr Med. 2021 Feb;163(3):58-65. doi: 10.1007/s15006-021-9557-8. German. PMID: 33591524.
Copy Download .nbib Format: NLM
Lung cancer research and its citation on clinical practice guidelines.

Lung cancer (Amsterdam, Netherlands)

Pallari E, Eriksson M, Billhult A, Billhult T, Aggarwal A, Lewison G, Sullivan R.
PMID: 33611225
Lung Cancer. 2021 Apr;154:44-50. doi: 10.1016/j.lungcan.2021.01.024. Epub 2021 Feb 05.

BACKGROUND: The impact of medical research is usually judged on the basis of citations in the serial literature. A better test of its utility is through its contribution to clinical practice guidelines (CPGs) on how to prevent, diagnose, and...

Cite
Pallari E, Eriksson M, Billhult A, et al. Lung cancer research and its citation on clinical practice guidelines. Lung Cancer. 2021;154:44-50doi: 10.1016/j.lungcan.2021.01.024.
Pallari, E., Eriksson, M., Billhult, A., Billhult, T., Aggarwal, A., Lewison, G., & Sullivan, R. (2021). Lung cancer research and its citation on clinical practice guidelines. Lung cancer (Amsterdam, Netherlands), 15444-50. https://doi.org/10.1016/j.lungcan.2021.01.024
Pallari, Elena, et al. "Lung cancer research and its citation on clinical practice guidelines." Lung cancer (Amsterdam, Netherlands) vol. 154 (2021): 44-50. doi: https://doi.org/10.1016/j.lungcan.2021.01.024
Pallari E, Eriksson M, Billhult A, Billhult T, Aggarwal A, Lewison G, Sullivan R. Lung cancer research and its citation on clinical practice guidelines. Lung Cancer. 2021 Apr;154:44-50. doi: 10.1016/j.lungcan.2021.01.024. Epub 2021 Feb 05. PMID: 33611225.
Copy Download .nbib Format: NLM
[Immunotherapy adaptation in lung cancer during the COVID-19 pandemic].

Revue des maladies respiratoires

Travert C, Cannone P, Greillier L, Tomasini P.
PMID: 34246519
Rev Mal Respir. 2021 Nov;38(9):865-872. doi: 10.1016/j.rmr.2021.06.005. Epub 2021 Jun 30.

INTRODUCTION: COVID-19 pandemics required changes in medical practices. In thoracic oncology, pembrolizumab was doubled to 400mg every 6weeks, nivolumab to 480mg every 4weeks. The objective of our study was to assess the impact on quality of life, and on...

Cite
Travert C, Cannone P, Greillier L, et al. COVID-19 et cancer bronchique : adaptation des schémas d’immunothérapie et qualité de vie. [Immunotherapy adaptation in lung cancer during the COVID-19 pandemic]. Rev Mal Respir. 2021;38(9):865-872doi: 10.1016/j.rmr.2021.06.005.
Travert, C., Cannone, P., Greillier, L., & Tomasini, P. (2021). COVID-19 et cancer bronchique : adaptation des schémas d’immunothérapie et qualité de vie. [Immunotherapy adaptation in lung cancer during the COVID-19 pandemic]. Revue des maladies respiratoires, 38(9), 865-872. https://doi.org/10.1016/j.rmr.2021.06.005
Travert, C, et al. "COVID-19 et cancer bronchique : adaptation des schémas d’immunothérapie et qualité de vie." [Immunotherapy adaptation in lung cancer during the COVID-19 pandemic]. Revue des maladies respiratoires vol. 38,9 (2021): 865-872. doi: https://doi.org/10.1016/j.rmr.2021.06.005
Travert C, Cannone P, Greillier L, Tomasini P. COVID-19 et cancer bronchique : adaptation des schémas d’immunothérapie et qualité de vie. [Immunotherapy adaptation in lung cancer during the COVID-19 pandemic]. Rev Mal Respir. 2021 Nov;38(9):865-872. doi: 10.1016/j.rmr.2021.06.005. Epub 2021 Jun 30. French. PMID: 34246519; PMCID: PMC8241593.
Copy Download .nbib Format: NLM
Early Palliative Care for Patients With Advanced Lung Cancer: Opportunities in the ED.

Chest

Jim Yeung SC, Elsayem A.
PMID: 33280746
Chest. 2020 Dec;158(6):2266-2267. doi: 10.1016/j.chest.2020.07.087.

No abstract available.

Cite
Jim Yeung SC, Elsayem A. Early Palliative Care for Patients With Advanced Lung Cancer: Opportunities in the ED. Chest. 2020;158(6):2266-2267doi: 10.1016/j.chest.2020.07.087.
Jim Yeung, S. C., & Elsayem, A. (2020). Early Palliative Care for Patients With Advanced Lung Cancer: Opportunities in the ED. Chest, 158(6), 2266-2267. https://doi.org/10.1016/j.chest.2020.07.087
Jim Yeung, Sai-Ching, and Elsayem, Ahmed. "Early Palliative Care for Patients With Advanced Lung Cancer: Opportunities in the ED." Chest vol. 158,6 (2020): 2266-2267. doi: https://doi.org/10.1016/j.chest.2020.07.087
Jim Yeung SC, Elsayem A. Early Palliative Care for Patients With Advanced Lung Cancer: Opportunities in the ED. Chest. 2020 Dec;158(6):2266-2267. doi: 10.1016/j.chest.2020.07.087. PMID: 33280746.
Copy Download .nbib Format: NLM
Associations Between Time to Treatment Start and Survival in Patients With Lung Cancer.

In vivo (Athens, Greece)

Stokstad T, Sørhaug S, Amundsen T, Grønberg BH.
PMID: 33910841
In Vivo. 2021 May-Jun;35(3):1595-1603. doi: 10.21873/invivo.12416.

BACKGROUND: Time-to-treatment is defined as a quality indicator for cancer care but is not well documented. We investigated whether meeting Norwegian timeframes of 35/42 days from referral until start of chemotherapy or surgery/radiotherapy for lung cancer was associated with...

Cite
Stokstad T, Sørhaug S, Amundsen T, et al. Associations Between Time to Treatment Start and Survival in Patients With Lung Cancer. In Vivo. 2021;35(3):1595-1603doi: 10.21873/invivo.12416.
Stokstad, T., Sørhaug, S., Amundsen, T., & Grønberg, B. H. (2021). Associations Between Time to Treatment Start and Survival in Patients With Lung Cancer. In vivo (Athens, Greece), 35(3), 1595-1603. https://doi.org/10.21873/invivo.12416
Stokstad, Trine, et al. "Associations Between Time to Treatment Start and Survival in Patients With Lung Cancer." In vivo (Athens, Greece) vol. 35,3 (2021): 1595-1603. doi: https://doi.org/10.21873/invivo.12416
Stokstad T, Sørhaug S, Amundsen T, Grønberg BH. Associations Between Time to Treatment Start and Survival in Patients With Lung Cancer. In Vivo. 2021 May-Jun;35(3):1595-1603. doi: 10.21873/invivo.12416. PMID: 33910841; PMCID: PMC8193294.
Copy Download .nbib Format: NLM
Feasibility of Aerobic Exercise and Tai-Chi Interventions in Advanced Lung Cancer Patients: A Randomized Controlled Trial.

Integrative cancer therapies

Cheung DST, Takemura N, Lam TC, Ho JCM, Deng W, Smith R, Yan Y, Lee AWM, Lin CC.
PMID: 34549648
Integr Cancer Ther. 2021 Jan-Dec;20:15347354211033352. doi: 10.1177/15347354211033352.

BACKGROUND: A majority of lung cancer patients are diagnosed at advanced stages. Although there is considerable evidence of the benefits of aerobic exercise and tai-chi for lung cancer patients, little is known about the comparative effectiveness of the 2...

Cite
Cheung DST, Takemura N, Lam TC, et al. Feasibility of Aerobic Exercise and Tai-Chi Interventions in Advanced Lung Cancer Patients: A Randomized Controlled Trial. Integr Cancer Ther. 2021;20:15347354211033352doi: 10.1177/15347354211033352.
Cheung, D. S. T., Takemura, N., Lam, T. C., Ho, J. C. M., Deng, W., Smith, R., Yan, Y., Lee, A. W. M., & Lin, C. C. (2021). Feasibility of Aerobic Exercise and Tai-Chi Interventions in Advanced Lung Cancer Patients: A Randomized Controlled Trial. Integrative cancer therapies, 2015347354211033352. https://doi.org/10.1177/15347354211033352
Cheung, Denise Shuk Ting, et al. "Feasibility of Aerobic Exercise and Tai-Chi Interventions in Advanced Lung Cancer Patients: A Randomized Controlled Trial." Integrative cancer therapies vol. 20 (2021): 15347354211033352. doi: https://doi.org/10.1177/15347354211033352
Cheung DST, Takemura N, Lam TC, Ho JCM, Deng W, Smith R, Yan Y, Lee AWM, Lin CC. Feasibility of Aerobic Exercise and Tai-Chi Interventions in Advanced Lung Cancer Patients: A Randomized Controlled Trial. Integr Cancer Ther. 2021 Jan-Dec;20:15347354211033352. doi: 10.1177/15347354211033352. PMID: 34549648; PMCID: PMC8461121.
Copy Download .nbib Format: NLM
Showing 217 to 222 of 222 entries